ArticleNature communications2026

Author Correction: First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort IKF-AIO-MOONLIGHT trial.

Sylvie Lorenzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.